Dyspnea Market Outlook 2026–2035: Growth Drivers and Industry Forecast

Uncover key drivers, emerging technologies, and competitive movements shaping the dyspnea market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Dyspnea Market be in 2030 compared with 2026?

The dyspnea market size has shown substantial growth over recent years. It is anticipated to expand from $6.73 billion in 2025 to $7.22 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. This market’s historical growth can be attributed to factors such as the prevalence of chronic respiratory diseases, the volume of hospital emergency admissions, smoking-related disorders, the aging population, and the burden of cardiopulmonary diseases.

The dyspnea market size is anticipated to undergo significant expansion over the next few years. It is forecast to grow to $9.5 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This growth during the projection period is driven by the demand for portable oxygen systems, advancements in remote respiratory monitoring, the implementation of personalized dyspnea management strategies, the expansion of homecare services, and the adoption of digital symptom tracking. Major trends for the forecast duration include the increasing use of oxygen therapy devices, a rise in the adoption of home-based respiratory care, a greater emphasis on symptom management therapies, the integration of breathing and relaxation techniques, and improved diagnostic assessment of respiratory disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21178&type=smp

What Drivers Are Guiding Growth Patterns In The Dyspnea Market?

The escalating incidence of respiratory illnesses is anticipated to drive the future expansion of the dyspnea market. These conditions, which impair airflow and reduce oxygen exchange by affecting the lungs and respiratory system, are becoming more widespread due to factors like air pollution, smoking, environmental toxins, climate change, and increased susceptibility in aging populations. The dyspnea market aligns with this trend, as dyspnea is a vital indicator of impaired lung function, aiding clinicians in diagnosing respiratory conditions, guiding treatment plans, and monitoring disease progression. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, COPD contributed to 3.6% of the total disease burden and accounted for 50% of the overall burden of respiratory diseases. Additionally, in 2022, COPD was the primary cause of 7,691 deaths, with a mortality rate of 29.6 per 100,000 people, representing 4.0% of all deaths. Therefore, the growing prevalence of respiratory diseases is a key factor propelling the growth of the dyspnea market.

Which Segments Are Driving Activity In The Dyspnea Market?

The dyspnea market covered in this report is segmented –

1) By Treatment Type: Supplemental Oxygen Therapy, Relaxation Therapy

2) By Drug Class: Antianxiety, Antibiotics, Anticholinergic Agents, Corticosteroids, Other Drug Classes

3) By Route Of Administration: Oral, Inhalation, Other Route Of Administrations

4) By End User: Hospitals, Homecare, Specialty Clinics, Ambulatory Services, Other End Users

Subsegments:

1) By Supplemental Oxygen Therapy: Continuous Flow Oxygen Therapy, Pulse Dose Oxygen Therapy, Oxygen Concentrators, Portable Oxygen Cylinders

2) By Relaxation Therapy: Breathing Exercises, Meditation and Mindfulness, Progressive Muscle Relaxation, Biofeedback Therapy

Which Trends Are Expected To Influence The Dyspnea Market In The Upcoming Years?

Major companies in the dyspnea market are concentrating on developing novel drug therapies, such as phosphodiesterase (PDE) inhibitors, to enhance treatment effectiveness, alleviate respiratory symptoms, and offer improved relief for patients experiencing chronic breathing difficulties. A phosphodiesterase (PDE) inhibitor functions by blocking PDE enzymes, thereby raising intracellular cyclic AMP or cyclic GMP levels, which in turn promotes bronchodilation, reduces inflammation, and boosts overall respiratory function. For example, in May 2024, Verona Pharma Plc, a UK-based biopharmaceutical company, announced its preparations for the anticipated U.S. launch of ensifentrine. This is a first-in-class dual PDE3/4 inhibitor for chronic obstructive pulmonary disease (COPD), expected in Q3 2024 pending FDA approval. Ensifentrine, delivered via nebulization, has demonstrated significant reductions in COPD exacerbation rates and meaningful improvements in dyspnea in Phase III trials. Verona secured $650 million in financing to support its commercial rollout and further development, which includes a planned Phase II fixed-dose combination trial with glycopyrrolate for maintenance COPD therapy.

Which Key Market Players Are Investing In Expansion And Innovation Within The Dyspnea Market?

Major companies operating in the dyspnea market are Pfizer Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca, Novartis AG, GlaxoSmithKline, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Amneal Pharmaceuticals LLC, Lupin Ltd, Inogen Inc, Fisher & Paykel Healthcare, ResMed Inc, Koninklijke Philips N.V, Masimo Corporation, Breas Medical, PARI Medical Holding GmbH, BMC Medical, Hamilton Medical, Nihon Kohden Corporation, Cipla Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/dyspnea-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Dyspnea Market?

North America was the largest region in the dyspnea market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dyspnea market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Dyspnea Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21178&type=smp

Browse Through More Reports Similar to the Global Dyspnea Market 2026, By The Business Research Company

Airway Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/airway-stent-global-market-report

Dysphagia Supplement Market Report 2026

https://www.thebusinessresearchcompany.com/report/dysphagia-supplement-global-market-report

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795